CD44 and cholangiocarcinoma: In this study, the enhanced interaction between MIF and CD74 + CD44 in cholangiocarcinoma may inhibit tumor apoptosis and promote angiogenesis by activating the downstream PI3K/Akt signaling pathway [24].